Search results
Results from the WOW.Com Content Network
In general, contraindications to antipsychotic switching are cases in which the risk of switching outweighs the potential benefit. Contraindications to antipsychotic switching include effective treatment of an acute psychotic episode, patients stable on a LAI antipsychotic with a history of poor adherence, and stable patients with a history of self-injurious behavior, violent behavior, or ...
Switching directly is usually only a safe option for switching between certain SSRIs and SNRIs with short half-lives, as these medications are less likely to cause drug interactions or unwanted ...
Olanzapine (Zyprexa) – approved as an adjunct to antidepressant for major depression Quetiapine (Seroquel) – approved as an adjunct to antidepressant or mood stabilizer for major depression and bipolar depression
The atypical antipsychotics (AAP), also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs), [1] [2] are a group of antipsychotic drugs (antipsychotic drugs in general are also known as tranquilizers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) largely introduced after the 1970s and used to treat psychiatric ...
Seroquel, Seroquel Xr, others: ... followed by olanzapine and ... switching to these atypicals is an option to minimize symptoms of tardive dyskinesia caused by other ...
In the U.S., Zyprexa (olanzapine) is approved by the FDA for the treatment of schizophrenia and bipolar disorder. In 2010 , Zyprexa's worldwide revenues were just over $5 billion, or nearly 22% of ...
Efficacy in therapy resistant cases is the most obvious one. Olanzapine is being studied in therapy resistant cases. If olanz.apine's labeling would include therapy resistant cases apart from I st line use, it could take quite some market share from Risperdal. Scenario: Risperdal will lose market leadership in <: 2000 in the schizophrenia
Ron Vachris, CEO of the warehouse retail giant, announced that Costco would be switching its food court fountains to Coca-Cola products during the company's shareholder meeting Thursday.